Chondrosarcoma natural history: Difference between revisions

	Chondrosarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chondrosarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chondrosarcoma natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chondrosarcoma natural history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chondrosarcoma natural history
CDC on Chondrosarcoma natural history
Chondrosarcoma natural history in the news
Blogs on Chondrosarcoma natural history
Directions to Hospitals Treating Chondrosarcoma
Risk calculators and risk factors for Chondrosarcoma natural history

Revision as of 19:18, 28 August 2015

Chondrosarcoma may return and may need treatment with surgery, chemotherapy or radiation.

Generally, chondrosarcoma carries a good prognosis.
Chondrosarcoma is associated with a 5 year survival rate of 75%.
Depending upon the subtype, prognosis vary substantially:
- Chondrosarcoma NOS: 70% 5 year survival.
- Myxoid chondrosarcoma: 70% 5 year survival.
- Mesenchymal chondrosarcoma: 50% 5 year survival.
- Dedifferentiated chondrosarcoma: 10% 5 year survival.
Prognosis varies with grade:
- Grade 1: 90% 5 year survival.
- Grade 3: 29% 5 year survival
Prognosis varies with location:
- long bones have a better prognosis than axial skeleton.

@@ Line 8: / Line 8: @@
 *Chondrosarcoma is associated with a 5 year survival rate of 75%.
 *Depending upon the subtype, prognosis vary substantially:
-**Chondrosarcoma NOS: 5 year survival of approximately 70%.
+**Chondrosarcoma NOS: 70% 5 year survival.
-**Myxoid chondrosarcoma: 5 year survival of approximately 70%.
+**Myxoid chondrosarcoma: 70% 5 year survival.
-**Mesenchymal chondrosarcoma: 5 year survival of approximately 50%.
+**Mesenchymal chondrosarcoma: 50% 5 year survival.
-**Dedifferentiated chondrosarcoma: 5 year survival of 10%.
+**Dedifferentiated chondrosarcoma: 10% 5 year survival.
+*Prognosis varies with grade:
+**Grade 1: 90% 5 year survival.
+**Grade 3: 29% 5 year survival
+*Prognosis varies with location:
+**long bones have a better prognosis than axial skeleton.
 ==References==
 {{reflist|2}}